Kimyrsa Interactions
There are 126 drugs known to interact with Kimyrsa (oritavancin), along with 4 disease interactions. Of the total drug interactions, 10 are major, 106 are moderate, and 10 are minor.
- View Kimyrsa disease interactions (4)
Medications known to interact with Kimyrsa
Note: Showing generic names only.
A
B
C
- cabozantinib
- capivasertib
- capmatinib
- cariprazine
- cholera vaccine, live
- cobicistat
- copanlisib
- crizotinib
D
E
- elacestrant
- elagolix
- elvitegravir
- encorafenib
- enfortumab vedotin
- entrectinib
- ergonovine
- ergotamine
- erlotinib
- estradiol
- ethinyl estradiol
- everolimus
F
- fecal microbiota spores, live
- fecal microbiota, live
- fenfluramine
- fentanyl
- finerenone
- fostamatinib
- fostemsavir
G
H
I
L
- lapatinib
- larotrectinib
- lefamulin
- lemborexant
- lenacapavir
- leniolisib
- lidocaine
- lonafarnib
- lumateperone
- lurasidone
- lurbinectedin
M
- macimorelin
- macitentan
- maribavir
- mavacamten
- mefloquine
- methadone
- methylergonovine
- methysergide maleate
- midostaurin
- mobocertinib
- mycophenolate mofetil
- mycophenolic acid
N
O
P
Q
R
S
- selpercatinib
- selumetinib
- silodosin
- sirolimus protein-bound
- sorafenib
- sotorasib
- sparsentan
- sunitinib
T
U
V
W
Z
Kimyrsa disease interactions
There are 4 disease interactions with Kimyrsa (oritavancin) which include:
More about Kimyrsa (oritavancin)
- Kimyrsa consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glycopeptide antibiotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.